Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
Fecundity in women with multiple sclerosis: an observational mono-centric study.
Lifestyle shapes the dialog between environment, microglia, and adult neurogenesis.
Gait characteristics of multiple sclerosis patients in the absence of clinical disability.
Assessments of nursing home guidelines for quality of care provided to residents with multiple sclerosis.
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling.
Assessment of the effect of cigarette smoking on regional brain volumes and lesion load in patients with clinically isolated syndrome.
Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced demyelination and spontaneous remyelination.
Feasibility study design and methods for Project GEMS: Guidelines for Exercise in Multiple Sclerosis.
Hypomyelination following deletion of Tsc2 in oligodendrocyte precursors.
Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.
Evaluator-blinded trial evaluating nurse-led immunotherapy DEcision Coaching In persons with relapsing-remitting Multiple Sclerosis (DECIMS) and accompanying process evaluation: study protocol for a cluster randomised controlled trial.
A gene expression study denies the ability of 25 candidate biomarkers to predict the interferon-beta treatment response in multiple sclerosis patients.
Ultrasound of inherited vs. acquired demyelinating polyneuropathies.
Progressive multifocal leukoencephalopathy in an immunocompetent patient?
Design of oral agents for the management of multiple sclerosis: benefit and risk assessment for dimethyl fumarate.
Characteristics of demyelinating Charcot-Marie-Tooth disease with concurrent diabetes mellitus.
[Future issues of the multiple sclerosis treatment from a medical economic viewpoint].
Metabolic response to epigallocatechin-3-gallate in relapsing-remitting multiple sclerosis: a randomized clinical trial.
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair.
Measurement and maintenance of reserve in multiple sclerosis.
Prevalence of neurofascin-155 antibodies in patients with multiple sclerosis.
Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms - A pilot study.
Multiple perspectives on the health service need, use, and variability among older adults with multiple sclerosis.
Pages
« first
‹ previous
…
696
697
698
699
700
701
702
703
704
…
next ›
last »